06 Jul 2021 by admin in UncategorizedComments NextCure Initiates Phase 1/2 Clinical Trial of NC762 for Solid Tumors
01 Jul 2021 by admin in UncategorizedComments Tempest Announces Appointment of Christine Pellizzari to its Board of Directors
28 Jun 2021 by admin in UncategorizedComments Tempest Closes Merger with Millendo and Completes PIPE Financing
22 Jun 2021 by admin in UncategorizedComments Tempest and Millendo Announce Stockholder Approval of Merger
21 Jun 2021 by admin in UncategorizedComments NextCure and Collaborators Publish Preclinical Data on Novel Immunomedicine NC410
07 Jun 2021 by admin in UncategorizedComments Design Therapeutics Expands Board of Directors with Key Appointments